Shyama Sidique

Title: Shyama Sidique: Innovator in CNS Disorder Treatments

Introduction

Shyama Sidique is an accomplished inventor based in La Jolla, California. He has made significant contributions to the field of neuroscience, particularly in the development of treatments for central nervous system (CNS) disorders. His innovative work has led to the granting of a patent that addresses critical health issues.

Latest Patents

Shyama Sidique holds a patent for "Positive allosteric modulators of group II mGluRs." This patent provides compounds and compositions, along with methods for using these compounds, as positive allosteric modulators of the metabotropic glutamate subtype 2 (mGlu2) receptor. The invention aims to treat CNS disorders associated with the mGlu2 receptor, including schizophrenia, anxiety, and various forms of addiction, such as cocaine and nicotine addiction. He has 1 patent to his name.

Career Highlights

Throughout his career, Shyama Sidique has worked with notable institutions, including the Sanford-Burnham Medical Research Institute and the University of California. His research has focused on developing innovative solutions for complex neurological conditions, showcasing his dedication to advancing medical science.

Collaborations

Shyama has collaborated with esteemed colleagues, including Nicholas D. P. Cosford and Dhanya Raveendra Panickar. Their combined expertise has contributed to the success of his research endeavors.

Conclusion

Shyama Sidique's work in developing positive allosteric modulators represents a significant advancement in the treatment of CNS disorders. His innovative approach and dedication to research continue to inspire progress in the field of neuroscience.